Alerts will be sent to your verified email
Verify Email
SUDARSHAN
|
Sudarshan Pharma Ind
|
Anlon Healthcare
|
Kopran
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
11.77 % | 35.86 % | 12.69 % |
|
5yr average Equity Multiplier
|
3.38 | 19.54 | 1.57 |
|
5yr Average Asset Turnover Ratio
|
1.89 | 0.72 | 0.87 |
|
5yr Avg Net Profit Margin
|
2.0 % | 9.13 % | 8.93 % |
|
Price to Book
|
4.44 | 3.0 | 1.29 |
|
P/E
|
38.99 | 31.4 | 39.18 |
|
5yr Avg Cash Conversion Cycle
|
121.83 Days | 215.12 Days | 100.24 Days |
|
Inventory Days
|
54.87 Days | 146.25 Days | 84.74 Days |
|
Days Receivable
|
102.16 Days | 172.55 Days | 123.83 Days |
|
Days Payable
|
70.3 Days | 138.78 Days | 98.33 Days |
|
5yr Average Interest Coverage Ratio
|
2.61 | 3.68 | 10.74 |
|
5yr Avg ROCE
|
23.07 % | 16.7 % | 17.11 % |
|
5yr Avg Operating Profit Margin
|
4.55 % | 17.87 % | 13.59 % |
|
5 yr average Debt to Equity
|
0.99 | 13.59 | 0.22 |
|
5yr CAGR Net Profit
|
42.99 % | n/a | -8.95 % |
|
5yr Average Return on Assets
|
3.51 % | 5.99 % | 7.93 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
57.39 % | 52.68 % | 44.42 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
-31.89 % | 0.0 | 0.12 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Sudarshan Pharma Ind
|
Anlon Healthcare
|
Kopran
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|
Location Wise Break-Up
|